Product category:
Nucleic acid sequencing and synthesis
News Release from: Amaxa
Edited by the Laboratorytalk Editorial
Team on 04 April 2008
Simplified monitoring of signaling in
stem cells
Amaxa and Promega will provide cell biologists broader access to monitor cell signaling events in difficult-to- transfect cells, including stem cells, cancer cells and primary cells
Integrating their industry leading technologies in luminescence-based assays and transfection methodologies will simplify transfection of reporter genes and assay development in these difficult-to-transfect cell types Amaxa's Nucleofector Technology enables unprecedented transfection capability and consistent performance in applications involving more biologically relevant mammalian systems, such as primary cells and stem cells
This article was originally published on Laboratorytalk on 4 Jul 2007 at 8.00am (UK)
Related stories
High-throughput tool for primary cell transfection
The devices developed using Amaxa's Nucleofector technology will be the world's first technology enabling high-throughput screenings in efficiently transfected and differentiated primary cells
HudsonAlpha Institute adopts Nucleofector
The HudsonAlpha Institute for Biotechnology will utilise Amaxa's Nucleofector technology as a core technology in certain research projects
"With the Nucleofector technology, transfection efficiencies of up to 95% using DNA and 99% using siRNA oligonucleotides can be achieved in difficult-to-transfect cells.
"Thus, the combination of Promega's and Amaxa's technologies will enable researchers to obtain much more significant results with physiologically relevant cells rather than more artifical cell lines" said Rainer Christine, co-founder and CEO, Amaxa.
Introducing the Nucleofector 96-well shuttle system has expanded use of the technology to high-throughput applications such as drug screening.
Promega luciferase reporter gene vectors and assay reagents are the most sensitive bioluminescent tools to monitor cell signaling events and provide the widest dynamic range in reporter assay technologies.
"Luciferase reporters are routinely used to monitor gene expression and are ideal tools for high-throughput screening, RNAi-mediated gene regulation and detection of cellular metabolism and viability.
"The combination of Promega's luciferase products and Amaxa's technology will enable the generation of stable cell lines and bioluminescent cell-based assays even for primary cells" said John Watson, director of cellular analysis, Promega.
• Amaxa: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
